AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2016
Feb 1, 2016
31982_dirs_2016-02-01_d9907aa9-2353-42b9-a0db-096c44f96d3f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2016-01-31
Reporting Person: Erck Stanley C (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-01-31 | Common Stock | P | 2072 | $4.38 | Acquired | 103057 | Direct |
Footnotes
F1: Includes 2,072 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on January 31, 2016.